Labeling

Browse Labeling Content

On behalf of the Consumer Healthcare Products Association, enclosed herein are comments on the 2019 revised draft guidance document as well as FDA’s decision to revoke CPG 400.400.

May 19, 2020

Modernizing food and dietary supplement labels is in the best interest of consumers and industry alike. Supplement facts labels serve as a trusted source of information and provide a consistent way to comprehend nutrient content.

Jul 22, 2019

Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics).

Nov 6, 2018

CHPA applauds CRN and UL for spearheading the Supplement OWL, which will prove to be a valuable resource for regulators, retailers and ultimately consumers.

Apr 13, 2017

CHPA appreciates the opportunity to provide information relevant to use of the term “natural” in food labeling, and believes that a formal definition will help to reduce consumer confusion and provide clarity to manufacturers and marketers making claims relying upon such a definition.

May 10, 2016

CHPA appreciates the opportunity to provide information on features to add and potential functionality improvements to make the Dietary Supplement Label Database a more useful tool for regulators, consumers, and other users of the database.

Dec 31, 2015

CHPA applauds FDA's efforts to amend labeling regulations for conventional foods and dietary supplements in order to provide updated nutrition information to consumers.

Aug 1, 2014

The Petitioners request that the Commissioner of Food and Drugs add a warning to the labeling of all nonprescription drug products containing an ingredient with “anticholinergic or histamine H1 inverse agonist effects” noting that the product can cause a confusional state.

Jun 3, 2014

CHPA requests that FDA publish a statement of enforcement policy expressly permitting manufacturers of single-ingredient acetaminophen OTC drugs subject to the ongoing internal analgesic, antipyretic, and antirheumatic monograph proceedings to including labeling on products that provide instructions for use in children aged six months to two years.

Aug 15, 2013

Filter Results